Microsporidiosis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Microsporidiosis}}
{{Microsporidiosis}}
{{CMG}}; {{AE}} {{Ochuko}} {{AY}}
{{CMG}}; {{Ochuko}};{{AE}}{{AY}}


==Overview==
==Overview==
The overall [[prevalence]] is not accurately estimated especially in the whole population (because microsporidiosis is usually investigated in [[Immunocompromised|immunocompromised patients]] with correlating [[gastrointestinal tract]] symptoms to microsporidiosis). The disease is present all over the world. In [[HIV]] patients with [[diarrhea]], the [[prevalence]] of microsporidiosis was 39% being the most common isolated organism.
The overall [[prevalence]] is not accurately estimated especially in the whole population (because microsporidIosis is usually investigated in [[Immunocompromised|immunocompromised patients]] with correlating [[Gastrointestinal tract|GIT]] symptoms to microsporidIosis). The disease is present all over the world. In [[HIV]] patients with [[diarrhea]], the [[prevalence]] of microsporidiosis was 39% being the most common isolated organism.


==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Prevalence:===
===Prevalence:===
*The overall [[prevalence]] is not accurately estimated especially in the whole population (because microsporidiosis is usually investigated in [[Immunocompromised|immunocompromised patients]] with correlating [[gastrointestinal tract]] symptoms to microsporidiosis).<ref name="pmid7942725">{{cite journal |vauthors=Kotler DP, Orenstein JM |title=Prevalence of intestinal microsporidiosis in HIV-infected individuals referred for gastroenterological evaluation |journal=Am. J. Gastroenterol. |volume=89 |issue=11 |pages=1998–2002 |year=1994 |pmid=7942725 |doi= |url=}}</ref><ref name="urlCDC - DPDx - Microsporidiosis">{{cite web |url=https://www.cdc.gov/dpdx/microsporidiosis/index.html |title=CDC - DPDx - Microsporidiosis |format= |work= |accessdate=}}</ref>
*The overall [[prevalence]] is not accurately estimated especially in the whole population (because microsporidiosis is usually investigated in [[Immunocompromised|immunocompromised patients]] with correlating [[gastrointestinal]] symptoms to microsporidiosis).<ref name="pmid7942725">{{cite journal |vauthors=Kotler DP, Orenstein JM |title=Prevalence of intestinal microsporidiosis in HIV-infected individuals referred for gastroenterological evaluation |journal=Am. J. Gastroenterol. |volume=89 |issue=11 |pages=1998–2002 |year=1994 |pmid=7942725 |doi= |url=}}</ref><ref name="urlCDC - DPDx - Microsporidiosis">{{cite web |url=https://www.cdc.gov/dpdx/microsporidiosis/index.html |title=CDC - DPDx - Microsporidiosis |format= |work= |accessdate=}}</ref>
*In [[HIV]] patients with [[diarrhea]], the [[prevalence]] of microsporidiosis was 39% being the most common isolated organism.
*In [[HIV]] patients with [[diarrhea]], the [[prevalence]] of microsporidiosis was 39% being the most common isolated organism.


Line 25: Line 25:
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Gastroenterology]]
[[Category:Digestive diseases]]
[[Category:Infectious disease]]
[[Category:Disease]]
[[Category:Needs content]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Revision as of 16:30, 16 August 2017

Microsporidiosis Microchapters

Home

Patient Information

Overview

Historical perspective

Classification

Pathophysiology

Causes

Differentiating Microsporidiosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory findings

X ray

CT

MRI

Other imaging studies

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Microsporidiosis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Microsporidiosis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Microsporidiosis epidemiology and demographics

CDC on Microsporidiosis epidemiology and demographics

Microsporidiosis epidemiology and demographics in the news

Blogs on Microsporidiosis epidemiology and demographics

Directions to Hospitals Treating Microsporidiosis

Risk calculators and risk factors for Microsporidiosis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Ogheneochuko Ajari, MB.BS, MS [2];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [3]

Overview

The overall prevalence is not accurately estimated especially in the whole population (because microsporidIosis is usually investigated in immunocompromised patients with correlating GIT symptoms to microsporidIosis). The disease is present all over the world. In HIV patients with diarrhea, the prevalence of microsporidiosis was 39% being the most common isolated organism.

Epidemiology and Demographics

Prevalence:

Case fatality rate:

Race

  • There is no racial predilection to the microsporidiosis.[3]

Age

  • Patients of all age groups may develop microsporidiosis.[3]

Sex

  • Males and females are affected equally by microsporidiosis.[3]

Geographic distribution

  • Microsporidiosis infections occur worldwide with no geographic predilection.[2]

References

  1. Kotler DP, Orenstein JM (1994). "Prevalence of intestinal microsporidiosis in HIV-infected individuals referred for gastroenterological evaluation". Am. J. Gastroenterol. 89 (11): 1998–2002. PMID 7942725.
  2. 2.0 2.1 "CDC - DPDx - Microsporidiosis".
  3. 3.0 3.1 3.2 Didier ES, Weiss LM (2006). "Microsporidiosis: current status". Curr Opin Infect Dis. 19 (5): 485–92. doi:10.1097/01.qco.0000244055.46382.23. PMC 3109650. PMID 16940873.

Template:WikiDoc Sources